Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities HALO - Halozyme Therapeutics, Inc.
-96.9 M
LAST VALUE
51.16%
2 YEAR CAGR
-108.99%
5 YEAR CAGR
-7.31%
10 YEAR CAGR